Study notes disparities in new drugs approved in the US and Japan
Regulatory NewsJoanne S. Eglovitch
AsiaPharmaceuticalsProduct developmentPublic healthRegulatory Intelligence/PolicyRegulatory strategyUnited StatesRegulatory NewsJoanne S. EglovitchAsiaPharmaceuticalsProduct developmentPublic healthRegulatory Intelligence/PolicyRegulatory strategyUnited States